Joseph Calabrese, MD, Psychiatry, Cleveland, OH, UH Cleveland Medical Center

JosephRCalabreseMD

Psychiatry Cleveland, OH

Director, Mood Disorders Program, UH Cleveland Medical Center. Professor, Psychiatry, CWRU School of Medicine.

Dr. Calabrese is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Calabrese's full profile

Already have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterResidency, Psychiatry, 1984 - 1986
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Psychiatry, 1980 - 1984
  • The Ohio State University College of Medicine
    The Ohio State University College of MedicineClass of 1980
  • Xavier UniversityB.S., Biology, Summa Cum Laude, 1972 - 1976

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1984 - 1986
  • OH State Medical License
    OH State Medical License 1981 - 2023
  • American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • Distinguished Life Fellow American Psychiatric Association, 2016
  • America's Top Doctors Castle Connolly, 2008-2014
  • Highly Cited as being one of the world’s most influential scientific minds within the section entitled: “Psychiatry/Psychology” Thompson Reuters, 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Efficacy and safety of aripiprazole once-monthly in the maintenance treatment of bipolar I disorder: a double-blind, placebo-controlled, randomized withdrawal study  
    Calabrese JR, Sanchez R, Jin D, Amatniek J, Cox K, Johnson B, Perry, Hertal P, Salzman PM, McQuate RD, Nyilas M, Carson WH, J Clin Psychiatry, 1/31/2017
  • Depression Severity and Quality of Life of Qualified and Unqualified Patients with a Mood Disorder for a Research Stuy Targeting Anhedonia in a Clinical Sample  
    Gao K, Sweet J, Su M, Calabrese J, Asian J Psychiatry, 1/1/2017
  • World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of ...  
    Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S; WFSBP Task Force on Treatment Guidelines for Bipolar Disorders, including Kasper S, Goodwin G, ..., World J Biol Psychiatry, 1/1/2013
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Monotherapy and Adjunctive Latuda for treatment of bipolar depression. 
    Sau Paulo, Brazil - 1/18/2016
  • Vincent van Gogh: Biography, Family History, and Artistic Genius. 
    Cleveland Clinic - 1/1/2016
  • Recognition and Treatment of Bipolar Disorder 
    Colombia; CARICAM; Mexico; Ecuador; Chile; Brazil; Argentina - 1/29/2015
  • Join now to see all

Other

  • Six subtle signs of depression you should never ignore. 
    Calabrese JR
    1/31/2016
  • Westside Arts Festival Shines Light on Mental Illness and Addiction. 
    Calabrese JR
    1/19/2016
  • Long-Acting Injectable Aripiprazole as a Potential Maintenance Treatment for Bipolar I Disorder. 
    Calabrese JR, Otsuka and Lundbeck Data at ACNP Annual Meeting
    1/17/2016
  • Join now to see all

Press Mentions

  • FDA Approves Abilify Maintena for Bipolar I Disorder Monotherapy Treatment
    FDA Approves Abilify Maintena for Bipolar I Disorder Monotherapy TreatmentAugust 8th, 2017
  • FDA Approves First Monthly Injectable for Bipolar Disorder
    FDA Approves First Monthly Injectable for Bipolar DisorderJuly 31st, 2017
  • LAI Aripiprazole Found to Reduce Recurrence of Mood Episodes
    LAI Aripiprazole Found to Reduce Recurrence of Mood EpisodesMarch 16th, 2017
  • Join now to see all

Grant Support

  • Psychosocial Intervention To Promote Treatment Adherence In CmchNational Institute Of Mental Health2007
  • Phenomenology And Identification Of Juvenile BPD In A Community SettingNational Institute Of Mental Health2007
  • Combination Therapy In Dual Diagnosis Rapid Cycling BPD In Both The Tertiary CareNational Institute Of Mental Health2007
  • Bipolar Disorder Across The Life SpanNational Institute Of Mental Health2003–2007
  • Combination Therapy In Bipolar Rapid CyclingNational Institute Of Mental Health2002–2004
  • Valproate Versus Lithium In Bipolar Rapid CyclingNational Institute Of Mental Health1995–1999
  • Valproate And Lithium In The Prophylaxis Of The Manic Phase Of Bipolar DisorderNational Institute Of Mental Health1996

Hospital Affiliations